SwissHealth Ventures

What SwissHealth Ventures does

SwissHealth Ventures is the corporate venture capital arm of CSS Group, a Swiss mutual health insurance association founded in 1899 that serves approximately 1.7 million insured persons in Switzerland. Established in 2020 and based in Luzern, SwissHealth Ventures operates a CHF 100 million fund dedicated to investing in early-stage digital health startups, with an explicit thematic focus on artificial intelligence and outpatient care delivery models. The fund's mandate is to back high-growth ventures whose innovations can be validated through and integrated into the broader CSS ecosystem, creating a strategic bridge between the incumbent Swiss health insurer and the European digital health startup landscape.

As a captive CVC rather than an externally funded VC, SwissHealth Ventures does not raise third-party limited partner capital; deployment is funded directly by CSS Group. The fund deploys capital predominantly at the seed stage, as demonstrated by its February 2026 co-lead of Oska Health's €11 million seed round (chronic disease management platform, Germany) alongside Capricorn Partners, and its co-lead of Hemi Health's €4 million seed round (migraine and concussion care, Denmark) alongside Denmark's EIFO. The portfolio construction strategy is explicitly pan-European, with active deals in Germany, Denmark, and the Netherlands alongside Switzerland, and recurring syndication with European sector-specialist investors such as EIFO, LBBW Venture Capital, GoHub Ventures, and Aurum Impact.

The fund's business model centers on strategic optionality and financial returns: portfolio companies gain access to CSS's domestic distribution, claims data, regulatory navigation expertise, and reimbursement pathway validation, while CSS gains early visibility into emerging care delivery and AI-driven therapy models that may inform future product strategy or operational integration. In December 2025, the fund volume was doubled from CHF 50 million to CHF 100 million to enable approximately twelve further investments. Operationally the entity is small (1–10 employees) and is not independently incorporated, functioning as an embedded innovation and venture arm within CSS Group.

Name

SwissHealth Ventures

Legal name

SwissHealth Ventures

Website

https://css.ch

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

SwissHealth Ventures is the corporate venture capital arm of Swiss health insurer CSS Group, operating a CHF 100 million fund that invests in early-stage European digital health startups focused on AI-driven care and outpatient treatment models.

Ownership category

akta.pro rank

Product category

Digital Health Venture Capital

NAICS

Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Corporate Fintech / Insurtech CVC (Financial-services-led CVC) (FSANAHAK)

akta.pro secondary industries

Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF), Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital
• Digital health
• Healthcare startups
• Startup funding
• Health tech investing

Headquarters

HQ city

Luzern

HQ country

Switzerland

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Core offering

SwissHealth Ventures is the corporate venture capital arm of CSS Group that invests seed and early-stage capital in European digital health startups. The fund deploys a CHF 100 million pool (doubled from CHF 50 million in December 2025) across roughly twelve portfolio investments, focusing on AI-driven care, outpatient treatment, and digital therapy startups such as Oska Health and Hemi Health.

Product overview

SwissHealth Ventures is the digital health investment arm of CSS, a Swiss health insurance company. It is an investment fund that supports high-growth digital health startups, with a focus on leveraging technological innovations like AI and outpatient treatment trends. The fund doubled its volume from CHF 50 million to CHF 100 million in December 2025, enabling approximately twelve further investments in healthcare sector startups.

Differentiator

Problem solved

Functional benefit

Products and services

• SwissHealth Ventures Digital Health Fund

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• BMHminorParticipated in the €11M seed funding round for Oska Health.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• Sanofi Ventures: The corporate venture capital arm of global pharmaceutical company Sanofi, investing in digital health and biotech startups. Directly comparable as a large strategic CVC deploying capital into healthcare innovation from a corporate parent.
• Novartis Venture Fund: Corporate venture capital arm of Novartis investing in innovative healthcare and digital health companies. Comparable as a strategic CVC from a major pharmaceutical/healthcare parent with similar fund-based investment model.
• Boehringer Ingelheim Venture Fund: Strategic venture arm of Boehringer Ingelheim focused on early-stage biotech and digital health. Directly comparable as a healthcare CVC backing innovative startups, particularly in Europe.
• Debiopharm Innovation Fund: Strategic investment arm of Swiss biopharmaceutical company Debiopharm investing in digital health and therapeutics. Comparable as a Switzerland-based healthcare CVC with similar corporate-parent-funded structure.
• Capricorn Partners: Belgium-based venture capital firm investing in digital health and technology. Directly comparable as a European digital health VC that has co-led deals with SwissHealth Ventures (e.g., Oska Health).
• EIFO (Export and Investment Fund of Denmark): Denmark's national export and investment fund actively co-leading European digital health seed rounds (e.g., Hemi Health with SwissHealth Ventures). Comparable as a strategic investor in European digital health with similar fund-based deployment model.

Regional players

• Swisscom Ventures: Corporate venture arm of Swiss telecom incumbent Swisscom, investing in Swiss and European technology and digital health startups. Comparable as another Swiss-headquartered strategic CVC operating in overlapping verticals.
• LBBW Venture Capital: Venture capital subsidiary of German Landesbank LBBW investing in technology and digital health. Comparable as a German corporate VC that has co-invested in SwissHealth Ventures' deals (Oska Health).

Broad incumbents

• Speedinvest: European venture capital firm with a dedicated health and tech practice investing across DACH and broader Europe. Comparable as a larger, multi-stage European digital health investor with overlapping target geography.
• Plug and Play Tech Center: Global innovation platform and investor with a dedicated health vertical running accelerator programs and seed investments. Comparable as a broader digital health investor and ecosystem partner for early-stage startups.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SwissHealth Ventures